Immunogenicity and reactogenicity of acellular diphtheria/tetanus/pertussis vaccines given as a pre-school booster: effect of simultaneous administration of MMR

被引:19
|
作者
Miller, E
Waight, P
Laurichesse, H
Andrews, N
Thornton, C
Sesardic, D
Corbel, M
机构
[1] Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, Immunisat Div, London NW9 5EQ, England
[2] Publ Hlth Lab Serv, Ctr Appl Microbiol & Res, Salisbury SP4 0JG, Wilts, England
[3] Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England
关键词
diphtheria/tetanus/perlussis vaccines; MMR; pre-school booster;
D O I
10.1016/S0264-410X(01)00123-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Four acellular diphtheria/tetanus/pertussis (aDTP) vaccines were compared with two diphtheria/tetanus (DT) vaccines given as a pre-school booster to 1033 children aged 4 to < 6 years who had completed primary immunisation with DTP vaccine according to the UK 2, 3 and 4 month schedule; 71 children had received aDTP vaccine and the remaining 962 a whole cell DTP vaccine for primary immunisation. The effect of simultanous administration of a second dose of MMR vaccine was evaluated in 374 (37%). Overall, there was little difference in the frequency of post-vaccination symptoms in DT and aDTP vaccinees, although local reactions occurred more quickly in the aDTP group. The concomitant administration of MMR had no effect on local reactions or fever within 10 days, or on the proportions requiring a doctor's visit in the 4-6 week post-vaccination period. Local reactions 2 3 cm were higher on day 2 in children who had received aDTP for primary immunisation (erythema 32.4% vs. 17.4% for wDTP, P = 0.0012; swelling 28.2% vs. 15.5%, P = 0.0027). Pertussis antibody responses were consistent with the antigen content of the aDTP vaccines. All were more immunogenic with respect to PT - the only pertussis antigen which by itself has been shown to be protective in clinical trials - than a wDTP pre-school booster given in an earlier trial. MMR vaccine had no significant effect on antibody responses to either the pertussis or diphtheria and tetanus antigens. Diphtheria antibody responses in children who had received wDTP for-primary immunisation were 2.8 times higher than in those who had received aDTP vaccine (P < 0.0001); they were also higher in children who had received a single dose of a Haemophilus influenzae type b vaccine containing CRM197 conjugate after 12 months of age. For countries currently using DT vaccines as a pre-school booster, replacement with an aDTP vaccine is unlikely to have a perceptable effect on reactogenicity, at least in children given wDTP for primary immunisation, and would boost antibody levels to antigens known to be associated with protection. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:3904 / 3911
页数:8
相关论文
共 50 条
  • [1] Immunogenicity and reactogenicity of combined acellular pertussis/tetanus/low dose diphtheria vaccines given as a booster to UK teenagers
    Southern, J
    Andrews, N
    Burrage, M
    Miller, E
    [J]. VACCINE, 2005, 23 (29) : 3829 - 3835
  • [2] Immunogenicity and reactogenicity of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccines given concurrently with Haemophilus type b conjugate vaccine or as pentavalent vaccine
    Begue, P
    Stagnara, J
    VieLeSage, F
    Bernard, JC
    Xerri, B
    Abitol, V
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (08) : 787 - 794
  • [3] Immunogenicity and reactogenicity of two diphtheria-tetanus-whole cell pertussis vaccines in Iranian pre-school children, a randomized controlled trial
    Zarei, Saeed
    Jeddi-Tehrani, Mahmood
    Akhondi, Mohammad Mehdi
    Zeraati, Hojjat
    Ferydonfar, Amir Ali
    Nasernia, Jalaledin
    Tavangar, Banafsheh
    Shokri, Fazel
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (06) : 1316 - 1322
  • [4] Reactogenicity and immunogenicity at preschool age of a booster dose of two three-component diphtheria-tetanus-acellular pertussis vaccines in children primed in infancy with acellular vaccines
    Tozzi, AE
    Anemona, A
    Stefanelli, P
    Salmaso, S
    degli Atti, MLC
    Mastrantonio, P
    Giammanco, A
    [J]. PEDIATRICS, 2001, 107 (02) : E25
  • [5] Effect of injection site on reactogenicity and immunogenicity of acellular and whole-cell pertussis component diphtheria-tetanus-pertussis vaccines in infants
    Tapiainen, T
    Cherry, JD
    Heininger, U
    [J]. VACCINE, 2005, 23 (43) : 5106 - 5112
  • [6] Safety and reactogenicity of a low-dose Diphtheria-Tetanus-Acellular Pertussis vaccine (Boostrix™) in pre-school Indian children
    Bose, A.
    Dubey, A. P.
    Gandhi, D.
    Pandit, A.
    Raghu, M. B.
    Raghupathy, P.
    Rao, M. I. S.
    Verghese, V. P.
    Datta, S. K.
    Bock, H. L.
    [J]. INDIAN PEDIATRICS, 2007, 44 (06) : 421 - 424
  • [7] Immunogenicity and reactogenicity of an acellular, monovalent 4-component pertussis vaccine as a booster dose in pre-school and early schoolage children
    Stehr, K
    Heininger, U
    Uhlenbusch, R
    Angersbach, P
    Hackell, J
    Eckhardt, T
    [J]. MONATSSCHRIFT KINDERHEILKUNDE, 1997, 145 (01) : 30 - 36
  • [8] DIFFERENCES IN REACTOGENICITY AND ANTIGENICITY OF ACELLULAR AND STANDARD PERTUSSIS VACCINES COMBINED WITH DIPHTHERIA AND TETANUS IN INFANTS
    ANDERSON, EL
    BELSHE, RB
    BARTRAM, J
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (04): : 731 - 737
  • [9] Comparative reactogenicity and immunogenicity of booster doses of diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine and diphtheria-tetanus-inactivated poliovirus vaccine in preadolescents
    Bégué, PC
    Grimprel, EM
    Giovannangeli, MD
    Abitbol, VI
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (09) : 804 - 809
  • [10] Immunogenicity and safety of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children
    Collins, CL
    Salt, P
    McCarthy, N
    Chantler, T
    Lane, L
    Hemme, F
    Diggle, L
    Buttery, J
    Kitchin, NRE
    Moxon, ER
    Pollard, AJ
    [J]. VACCINE, 2004, 22 (31-32) : 4262 - 4269